• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. An automated computational approach to kinetic model discrimination and parameter estimation?
  Connor J. Taylor,Hikaru Seki,Friederike M. Dannheim,Mark J. Willis,Graeme Clemens,Brian A. Taylor,Thomas W. Chamberlain,Richard A. Bourne React. Chem. Eng., 2021,6, 1404-1411
• 5. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides
• Catalysts and Inorganic Chemicals Inorganic Compounds Oxides

Introduction to N,N-dimethylaminomethylferrocene (CAS No. 1271-86-9) and Its Emerging Applications in Chemical Biology and Medicinal Chemistry

N,N-dimethylaminomethylferrocene, identified by the chemical abstracts service number 1271-86-9, is a fascinating organometallic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its unique structural and electronic properties. This compound, featuring a ferrocene core substituted with a dimethylaminomethyl group, exhibits remarkable versatility as a building block for designing novel molecular architectures with potential applications in drug discovery, materials science, and catalysis. The ferrocene moiety, known for its stability and redox-active nature, combined with the electron-donating effect of the dimethylamino group, makes this compound a promising candidate for various biochemical and pharmaceutical investigations.

The structural framework of N,N-dimethylaminomethylferrocene (CAS No. 1271-86-9) consists of an iron(II) center sandwiched between two cyclopentadienyl rings, which are further functionalized with the dimethylaminomethyl substituent. This modification imparts enhanced solubility and reactivity compared to its unmodified counterpart, facilitating its incorporation into complex molecular systems. The presence of the ferrocene unit endows the compound with excellent stability under various conditions, including oxidation-reduction cycles, while the dimethylamino group enhances its ability to interact with biological targets such as enzymes and receptors.

In recent years, the applications of organometallic compounds like N,N-dimethylaminomethylferrocene (CAS No. 1271-86-9) have expanded significantly, particularly in the realm of medicinal chemistry. The redox-active nature of ferrocene derivatives has been exploited in the development of novel anticancer agents, where the ability to undergo reversible oxidation-reduction cycles can selectively target hypoxic tumor environments or induce apoptosis in cancer cells. Furthermore, the dimethylaminomethyl group serves as a versatile handle for further functionalization, allowing chemists to design molecules with tailored biological activities.

One of the most compelling aspects of N,N-dimethylaminomethylferrocene (CAS No. 1271-86-9) is its potential as a tool in chemical biology research. The compound's ability to modulate redox-sensitive signaling pathways has been explored in studies investigating cellular stress responses and neurodegenerative diseases. For instance, researchers have utilized ferrocene derivatives to develop probes that can track intracellular redox states in real time, providing insights into how oxidative stress contributes to disease pathogenesis. Additionally, the dimethylamino moiety has been leveraged to enhance binding affinity to specific biological targets, making this compound an attractive scaffold for rational drug design.

The synthetic utility of N,N-dimethylaminomethylferrocene (CAS No. 1271-86-9) cannot be overstated. Its modular structure allows for easy modification at multiple positions, enabling the creation of libraries of derivatives with diverse chemical and biological properties. This flexibility has been harnessed in high-throughput screening campaigns aimed at identifying novel therapeutic agents. Moreover, the compound's compatibility with various synthetic methodologies makes it a valuable intermediate in organic synthesis, particularly for constructing complex heterocyclic systems that are prevalent in biologically active molecules.

Recent advances in computational chemistry have further enhanced our understanding of how N,N-dimethylaminomethylferrocene (CAS No. 1271-86-9) interacts with biological targets. Molecular modeling studies have revealed that the compound can bind to specific pockets on enzymes and receptors through both electrostatic and hydrophobic interactions. The presence of the ferrocene unit provides a stable platform for these interactions, while the electron-rich dimethylamino group facilitates hydrogen bonding or other non-covalent interactions with polar residues in the binding site. These insights have guided the development of more potent and selective analogs with improved pharmacological profiles.

The role of N,N-dimethylaminomethylferrocene (CAS No. 1271-86-9) in materials science is also noteworthy. Ferrocene derivatives are known for their unique electronic properties, making them suitable candidates for applications in organic electronics and nanotechnology. For example, researchers have explored the use of ferrocene-based polymers as conductive materials in organic field-effect transistors (OFETs) and dye-sensitized solar cells (DSSCs). The incorporation of the dimethylamino group into these materials enhances their solubility and processability while maintaining their redox activity.

The future prospects for N,N-dimethyaminomethylerocence (CAS No. 1271-86-9) are exciting and multifaceted. Ongoing research is focused on expanding its applications in therapeutic areas such as immunotherapy and anti-inflammatory drugs. By leveraging its ability to modulate redox signaling pathways, this compound holds promise for developing novel immunomodulators that can regulate immune responses without triggering adverse side effects. Additionally, its potential as a diagnostic tool is being explored through the development of ferrocene-based biosensors capable of detecting biomarkers associated with various diseases.

In conclusion, N,N-dimethyaminomethylerocence(CAS No 1271 86 9) is a versatile organometallic compound with significant potential across multiple disciplines including chemical biology medicinal chemistry materials science In light recent advancements understanding molecular interactions computational modeling synthetic methodologies this compound continues emerge forefront scientific innovation With ongoing research efforts expect applications expand further solidifying position valuable tool advancing both academic industrial endeavors

• 5256-10-0(2-Oxazolidinone,3-(4-methylphenyl)-5-[(4-nitrophenoxy)methyl]-)
• 34490-85-2(4-(Aminomethyl)benzyldimethylamine Dihydrochloride)
• 56927-89-0(Benzenemethanamine,ar,N,N-trimethyl- (9CI))
• 10479-25-1(N-Ethyldibenzylamine)
• 23539-76-6(1,3,5-Benzenetrimethanamine,N1,N1,N3,N3,N5,N5-hexamethyl-)
• 4052-88-4(Benzenemethanamine,N,N,4-trimethyl-)
• 14800-24-9(Benzenemethanaminium,N,N,N-trimethyl-)
• 143171-90-8(1,4-Benzenedimethanaminium, N1,N1,N4,N4-tetramethyl-N1,N4-bis[[4-[(trimethylammonio)methyl]phenyl]methyl]-)
• 16652-03-2(Benzenemethanaminium,N,N,N-triethyl-)
• 28262-13-7(Benzenemethanamine,dimethyl- (9CI))